Cancer Letters
Volume 225, Issue 1 , Pages 27-33 , 8 July 2005

Survivin as prognostic factor in squamous cell carcinoma of the oral cavity

  • Lorenzo Lo Muzio

      Affiliations

    • Department of Surgery, University of Foggia, Via Carelli 28, 71100 Foggia, Italy
    • Corresponding Author InformationCorresponding author. Tel./fax: +39 0881 685809.
    • ,
  • Antonio Farina

      Affiliations

    • Institute of Histology, University of Bologna, Italy
    • ,
  • Corrado Rubini

      Affiliations

    • Institute of Pathology, University of Ancona, Italy
    • ,
  • Furio Pezzetti

      Affiliations

    • Institute of Histology, University of Bologna, Italy
    • ,
  • Giordano Stabellini

      Affiliations

    • Institute of Anatomy, University of Milano, Italy
    • ,
  • Gregorio Laino

      Affiliations

    • Department of Maxillofacial Surgery, Second University of Naples, Italy
    • ,
  • Andrea Santarelli

      Affiliations

    • Department of Surgery, University of Foggia, Via Carelli 28, 71100 Foggia, Italy
    • ,
  • Giuseppe Pannone

      Affiliations

    • Department of Surgery, University of Foggia, Via Carelli 28, 71100 Foggia, Italy
    • ,
  • Pantaleo Bufo

      Affiliations

    • Department of Surgery, University of Foggia, Via Carelli 28, 71100 Foggia, Italy
    • ,
  • Alfredo de Lillo

      Affiliations

    • Department of Surgery, University of Foggia, Via Carelli 28, 71100 Foggia, Italy
    • ,
  • Francesco Carinci

      Affiliations

    • Institute of Maxillofacial Surgery, University of Ferrara, Italy

Received 25 August 2004 ,Revised 3 November 2004 ,Accepted 6 November 2004.

References 

  1. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 1998;351:882–883
  2. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am. J. Pathol. 1998;152:43–49
  3. Altieri DC. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer. 2003;3:46–54
  4. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 1997;3:917–921
  5. Ambrosini G, Adida C, Sirugo G, Altieri DC. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem. 1998;273:11177–11182
  6. Chawla-Sarkar M, Bae SI, Reu FJ, Jacobs BS, Lindner DJ, Borden EC. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 2004;
  7. Chiodino C, Cesinaro AM, Ottani D, Fantini F, Giannetti A, Trentini GP, et al. Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J. Invest. Dermatol. 1999;113:415–418
  8. Crook NE, Clem RJ, Miller LK. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 1993;67:2168–2174
  9. Dawson-Saunders B, Trapp RG. Basic & Clinical Biostatistic. Norwalk: Appleton & Lange; 1994;
  10. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997;388:300–304
  11. Deveraux QL, Reed JC. IAP family proteins—suppressors of apoptosis. Genes Dev. 1999;13:239–252
  12. Glinsky GV, Glinsky VV, Ivanova AB, Hueser CJ. Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Lett. 1997;115:185–193
  13. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309–1312
  14. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13:1899–1911
  15. Grossman D, McNiff JM, Li F, Altieri DC. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab. Invest. 1999;79:1121–1126
  16. Grossman D, McNiff JM, Li F, Altieri DC. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J. Invest. Dermatol. 1999;113:1076–1081
  17. Grossman D, Kim PJ, Blanc-Brude OP, Brash DE, Tognin S, Marchisio PC, et al. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J. Clin. Invest. 2001;108:991–999
  18. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770–776
  19. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334–336
  20. Holciki M, Yeh C, Korneluk RG, Chow T. Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene. 2000;19:4174–4177
  21. International Union Against Cancer . TNM Classification of Malignant Tumours. New York: Wiley-Liss; 2000;
  22. Jameson JL. Principles of Molecular Medicine. Totowa, New Jersey: Humana Press; 1998;
  23. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 1998;58:5071–5074
  24. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998;17:3247–3259
  25. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396:580–584
  26. Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, et al Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol. 1999;1:461–466
  27. Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Rubini C, Mariggio MA, et al. Survivin expression in oral squamous cell carcinoma. Br. J. Cancer. 2003;89:2244–2248
  28. Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, et al. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J. Clin. Oncol. 1999;17:2100
  29. Salvesen GS, Duckett CS. IAP proteins blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 2002;3:401–410
  30. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ. Expression of the antiapoptosis gene. Survivin, predicts death from recurrent colorectal carcinoma. Gut. 2000;46:645–650
  31. Sasaki H, Sheng Y, Kotsuji F, Tsang BK. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res. 2000;60:5659–5666
  32. Sternberg SS. Histology for Pathologist. Philadelphia: Lippincott-Raven Publishers; 1997;
  33. Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N. Engl. J. Med. 1999;341:452–453
  34. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95). Bax, caspases, and anticancer drugs. Cancer Res. 1998;58:5315–5320
  35. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res. 2000;6:127–134
  36. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science. 2000;288:874–877

PII: S0304-3835(04)00873-0

doi: 10.1016/j.canlet.2004.11.024

Cancer Letters
Volume 225, Issue 1 , Pages 27-33 , 8 July 2005

Article Tools

* Image Usage & Resolution